Skip to content

Quality of Life After Breast Cancer Surgery

Assessing Quality of Life After Breast Cancer Surgery: a Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06761196
Acronym
SOCOM-QoL
Enrollment
1500
Registered
2025-01-07
Start date
2025-09-02
Completion date
2035-09-01
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Surgery, Quality of Life

Keywords

breast cancer, oncoplastic surgery, quality of life, quality of recovery

Brief summary

The goal of this observational study is to prospectively collect data on quality of life after oncoplastic breast surgery. Participants will be followed-up and answer quality of life questionnaire for a duration of 5 years after surgery.

Interventions

OTHERQuestionnaire

The quality of life measured with different scales (BREAST-Q, EORTC QLQ C30 and BR42)

Sponsors

Centre Hospitalier de Colmar
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient aged 18 or over * Patient with breast cancer of any stage (including in situ) or healthy individual at high personal risk. * Patient requiring breast surgery under general anesthesia, whether for therapeutic or prophylactic purposes. * Patient capable, in the opinion of the investigator, of complying with the requirements and restrictions of the study. * Patient with a computer, tablet or smartphone connected to the Internet. * Patient followed in the center on a regular basis according to standard recommendations.

Exclusion criteria

* Patient requiring surgical intervention under local anesthesia only. * Patient requiring surgery for the installation or removal of an chemotherapy implantable port only. * Patients with a history of cancer other than breast cancer. Patients with a history of cancer more than three years old are eligible if they are treated and considered cured. Patients with a history of cervical carcinoma in situ or non-melanoma skin carcinoma are eligible. * Impossibility of being subject to regular monitoring for geographical, social or psychological reasons. * Patient under protective measure

Design outcomes

Primary

MeasureTime frameDescription
Quality of life measured with BREAST-QFrom enrollment to the end of 5 years follow-upThe BREAST-Q is a rigorously developed patient-reported outcome measure for use in cosmetic and reconstructive breast surgery and clinical practice. The BREAST-Q conceptual framework covers 2 domains: quality of life, and patient satisfaction. There is three independent modules developped for breast cancer (mastectomy, breast-conserving therapy, reconstruction). A conversion table is used to convert the raw scale summed score into a score from 0 (worst) to 100 (best). Higher scores reflect a better outcome.

Secondary

MeasureTime frameDescription
Quality of life measured with EORTC QLQ C30From enrollment to the end of 5 years follow-upThe EORTC QLG Core Questionnaire (EORTC QLQ-C30) is a 30-item instrument designed to measure quality of life in all cancer patients. The QLQ-C30 is composed of both multi-item scales and single-item measures. These include five functional scales, three symptom scales, a global health status / QoL scale, and six single items. Each of the multi-item scales includes a different set of items - no item occurs in more than one scale. All of the scales and single-item measures range in score from 0 to 100. A high scale score represents a higher response level. Thus a high score for a functional scale represents a high / healthy level of functioning, a high score for the global health status / QoL represents a high QoL, but a high score for a symptom scale / item represents a high level of symptomatology / problems.
Quality of life measured with EORTC QLQ-BR42From enrollment to the end of 5 years follow-upThe Breast Cancer Module EORTC QLQ-BR42 is a 42-item instrument designed to measure quality of life in breast cancer patients. It is a supplementary questionnaire module to be employed in conjunction with the QLQ-C30. All of the scales and single item measures range in score from 0 to 100. A high score for the Body Image, Sexual Functioning and Breast Satisfaction scales and for the Future Perspective and Sexual Enjoyment single items represents a high level of functioning, whereas a high score for the Systemic ChemoTherapy Side Effects, Endocrine Symptoms, Arm Symptoms, Breast Symptoms, Hand/foot symptoms/neuropathy, Skeletal Scale and Vaginal Symptoms scales and for the Weight Gain single item represents a high level of symptomatology or problems.
Safety of postoperative periodForm enrollment to the end of 5 years follow-upConcerning safety, the endpoint is the duration of Hospital Free Survival (HFS) . HFS is defined as the time interval (in days) without any hospitalization from discharge until death.
Quality of postoperative periodAt enrollment aund day 1 and 7 after surgeryConcerning the quality of the postoperative period, the enpoint is the quality of recovery assessed with the 15-item Quality of Recovery (QoR-15) scale. The QoR-15 scale is a validated multidimensional questionnaire that measures postoperative quality of recovery. The scale is ranges from 0 to 150. A higher QoR-15 score reflects higher recovery.

Countries

France

Contacts

Primary ContactMassimo LODI, MD
massimo.lodi@ch-colmar.fr0033389124171
Backup ContactMagali EYRIEY
magali.eyriey@ch-colmar.fr0033389124810

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026